Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,121 across all filing types
Latest filing 2008-10-14 Director's Dealing
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, nature of the change, and consideration value. This is a report of personal share transactions by a company director, which fits the definition of Director's Dealing filings. The document length is 3476 characters, which is consistent with a detailed notice rather than a brief announcement or a full report like an annual report or earnings release. Therefore, the correct classification is Director's Dealing (DIRS).
2008-10-14 English
Change of Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of securities held before and after the change, nature of the change, and consideration paid. This is a report of personal share transactions by a company director. The document length is 4082 characters, which is consistent with a detailed notice rather than a brief announcement. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades).
2008-10-13 English
First successful pivotal trial complete 2 pages ?Kb
Capital/Financing Update Classification · 85% confidence The document is a press release announcing the successful completion of a pivotal clinical trial for a pharmaceutical product (SUBA-itraconazole). It discusses study results, market potential, and company strategy but does not contain financial statements, regulatory filings, or detailed financial data. It is not an earnings release, annual report, or any formal regulatory filing. The content is primarily an update on clinical trial progress and company product development, typical of a Capital/Financing Update or general corporate announcement. Given the focus on trial completion and market targeting, the best fit is Capital/Financing Update (CAP). The document length is under 5,000 characters and is a standalone announcement, not a report publication or certification.
2008-10-06 English
Full Year Statutory Accounts 54 pages ?Kb
Annual Report Classification · 100% confidence The document is titled 'FINANCIAL REPORT FOR THE YEAR ENDED 30 JUNE 2008' and contains detailed sections typical of an annual report, including Directors' Report, Auditor's Independence Declaration, Corporate Governance Statement, Income Statement, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement, Notes to the Financial Statements, Directors' Declaration, and Independent Auditor's Report. The presence of comprehensive financial statements and detailed management discussion indicates this is a full annual report. The document length is 15,000 characters, which is consistent with a full report rather than a brief announcement. Therefore, this document fits the definition of an Annual Report (10-K). FY 2008
2008-09-29 English
Preliminary Final Report 10 pages ?Kb
Annual Report Classification · 95% confidence The document is titled 'Appendix 4E Preliminary final report Year ended 30 June 2008' and contains detailed financial statements including income statement, balance sheet, cash flow statement, statement of changes in equity, and commentary on results for the year ended 30 June 2008. It includes comprehensive financial data and analysis for a full fiscal year, not just a summary or announcement. The presence of detailed financials and the term 'Preliminary final report' indicates this is a full annual financial report rather than a short earnings release or announcement. Appendix 4E is a regulatory form used in Australia for preliminary final reports, which are annual reports but preliminary and subject to audit. Given the detailed financial data and the annual period covered, this document fits best under the category of Annual Report (10-K equivalent). FY 2008
2008-08-28 English
Appendix 4C - quarterly 5 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4C Quarterly report for entities admitted on the basis of commitments' and contains detailed financial data including consolidated statement of cash flows, cash flow related to operating, investing, and financing activities, reconciliation of cash, and notes on compliance and accounting standards. The report covers a specific quarter ended 30 June 2008, indicating it is a periodic financial report shorter than a full fiscal year. The presence of substantive financial data and analysis confirms it is a quarterly report rather than a mere announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q4 2008
2008-07-30 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.